Latest News
April 22, 2024
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
April 7, 2024
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
March 20, 2024
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
March 20, 2024
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
March 11, 2024
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024